Prognostic relevance of immunohistochemical subclassification of diffuse large B-cell lymphoma in two prospective phase III clinical trials.
暂无分享,去创建一个
D. de Jong | P. Sonneveld | B. van der Holt | R. Delwel | L. Verdonck | A. Mulder | G. V. van Imhoff | K. Lam | L. Budel | N. Rayman | D. Veldhuizen | Clara Koss | Nazik Rayman